Pharmacists' discussions of medication side effects: A descriptive study

Patient Education and Counseling

Volumn 56, Issue 1, 2005, Pages 21-27

  Dyck, Andria ^a   Deschamps, Michelle ^a   Taylor, Jeff ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Patient counseling; Pharmacist; Side effects

Indexed keywords

AMOXICILLIN; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; CONTROLLED STUDY; DECISION MAKING; DRUG SAFETY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MEDICAL INFORMATION; NORMAL HUMAN; PATIENT COUNSELING; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; SIDE EFFECT;

ACUTE DISEASE; ADULT; AGED; CHRONIC DISEASE; COMMUNICATION; COMMUNITY PHARMACY SERVICES; COUNSELING; DECISION MAKING; DRUG LABELING; DRUG THERAPY; HUMANS; INFORMED CONSENT; PATIENT EDUCATION; PATIENT SIMULATION; PHARMACISTS; PILOT PROJECTS; PROFESSIONAL ROLE; PROFESSIONAL-PATIENT RELATIONS; RISK ASSESSMENT; SAFETY MANAGEMENT; SASKATCHEWAN; TEACHING MATERIALS; TIME AND MOTION STUDIES; VIDEOTAPE RECORDING;

EID: 10044219656     PISSN: 07383991     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pec.2003.10.006     Document Type: Article

References (32)

1. Model standards of practice for Canadian pharmacists. National Association of Pharmacy Regulatory Authorities (www.napra/org/docs/0/95/123.asp; 2002). Access date: 12 November 2002.
2. Howard J., Wildman K., Blain J., Wills S., Brown D. The importance of drug information from a patient perspective. J. Soc. Admin. Pharm. 16:1999;115-126
3. DeYoung M. A review of the research on pharmacists' patient-communication views and practices. Am. J. Pharm. Educ. 60:1996;60-77
4. Ali A., Horne R. Patients want more information: a survey of hospital patients' satisfaction with medicines information received and attitudes to medicines in general. Pharm. Pract. 6:1996;333-338
5. Ziegler D.K., Mosier M.C., Buenaver M., Okuyemi K. How much information about adverse effects of medication do patients want from physicians? Arch. Intern. Med. 161:2001;706-713
6. Ley P. Communicating with patients: improving communication, satisfaction and compliance. London: Chapman & Hall; 1988.
7. Prescription drug product labeling medication guide requirements proposed rule. Federal Register: August 1995;24:44182-252.
8. Airaksinen M., Vainio K., Koistinen J., Ahonen R., Wallenius S., Enlund H. Do the public and pharmacists share opinions about drug information? Int. Pharm. J. 8:1994;168-171
9. Mottram D.R., Reed C. Comparative evaluation of patient information leaflets by pharmacists doctors and the general public. J. Clin. Pharm. Ther. 22:1997;127-134
10. Coulter A. Partnerships with patients: the pros and cons of shared clinical decision-making. J. Health Serv. Res. Policy. 2:1997;112-121
11. Franic D.M., Pathak D.S. Communicating the frequency of adverse drug reactions to female patients. Drug Info. J. 34:2000;251-272
12. Koons Woloshin K., Ruffin M.T., Gorenflo D.W. Patients' interpretation of qualitative probability statements. Arch. Fam. Med. 3:1994;961-966
13. Fischer K., Jungerman H. Rarely occuring headaches and rarely occuring blindness: is rarely = rarely? J. Behav. Decis. Making. 9:1996;153-172
14. Berry D.C., Raynor D.K., Knapp P., Bersellini E. Patients' understanding of risk associated with medication use. Drug Safety. 26:2003;1-11
15. Berry D.C., Knapp P., Raynor D.K. Provision of information about side-effects to patients. Lancet. 359:2002;853-854
16. Tversky A., Kahneman D. The framing of decisions and the psychology of choice. Science. 211:1981;453-458
17. Schommer J.C., Doucette W.R., Worley M.M. Processing prescription drug information under different conditions of presentation. Pat. Educ. Couns. 43:2001;49-59
18. Lisper L., Isacson D., Sjoden P.-O., Bingefors K. Medicated hypertensive patients' views and experience of information and communication concerning antihypertensive drugs. Pat. Educ. Couns. 32:1997;147-155
19. John D.N., Housley W. Talk-in-interaction in the community pharmacy setting: a conversation analytic approach. Int. J. Pharm. Pract. 9(Suppl.):2001;R45
20. Pilnick A. 'Why didn't you say that?' Dealing with issues of assymetry. Soc. Health Illness. 20:1998;29-51
21. Pilnick A. "Patient counseling" by pharmacists: advice information, or instruction? Soc. Q. 40:1999;613-622
22. Deschamps M., Dyck A., Taylor J. What are we saying? Content and organization of patient counseling by community pharmacists. Can Pharm. J. 136(6):2003;42-47
23. Psathas G. Conversation analysis: the study of talk-in-interaction. Thousand Oaks (CA): Sage; 1995.
24. ten Have P. Methodological issues in conversation analysis. Ethno/CA News; 1990 (http://www.pscw.uva.nl/emca/mica.htm). Access date: 12 November 2002.
25. Svarstad B., Bultman D., Mount J., Tabak E. Evaluation of written prescription information provided in community pharmacies: a study in eight states. J. Am. Pharm. Assoc. 43:2003;383-393
26. Myers M.G. Compliance in hypertension: why don't patients take their pills? Can. Med. Assoc. J. 160:1999;64-65
27. Berry D.C., Michas I.C., De Rosis F. Evaluating explanations about drug prescriptions: effects of varying the nature of information about side effects and its relative position in explanations. Psych. Health. 13:1998;767-784
28. Fagerberg C.R., Kragstrup J., Stovring H., Rasmussen N.K. How well do patient and general practitioner agree about the content of consultations? Scand. J. Prim. Health Care. 17(3):1999;149-152
29. Knapp P., Berry D.C., Raynor D.K. Testing two methods of presenting side effect risk information about common medicines. Int. J. Pharm. Pract. 9(Suppl.):2001;R6
30. Berry D.C., Knapp P.R., Raynor T. Is 15 per cent very common? Informing people about the risks of medication side effects. Int. J. Pharm. Pract. 10:2002;145-151
31. Schommer J.C. Effects of interrole congruence on pharmacist-patient communication. Health Comm. 6:1994;297-309
32. Liu M.Y., Jennings P., Samuelson W.M., Sullivan C.A., Veltri J.C. Asthma patients' satisfaction with the frequency and content of pharmacist counseling. J. Am. Pharm. Assoc. 39:1999;493-498